在人类A3腺受体中结合联体和受体激活的分子基础
Liudi Zhang1,2, Jesse I Mobbs1,2, Felix M Bennetts1,2
1Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
Nature communications
|August 18, 2025
概括
高分辨率结构揭示了腺A3受体如何激活,揭示了药物开发至关重要的神秘口袋. 这有助于选择性治疗炎症性疾病,癌症和青光眼的治疗方法.
科学领域:
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 氨酸受体 (AR) 是主要的药物点,但开发选择性药物是具有挑战性的.
- 了解AR功能对于治疗炎症,癌症和玻璃眼等疾病至关重要.
研究的目的:
- 阐明人类A3AR激活和带结合的结构基础.
- 描述A3AR复合体与内源性激动剂,临床激动剂和性对抗剂的特征.
主要方法:
- 高分辨率冷电子显微镜 (cryo-EM) 用于确定A3AR结构.
- 局部定向突变发生和药理分析,以验证结构性发现.
主要成果:
- 确定人体A3AR与腺,皮克利登和LUF7602.2结合的冷EM结构.
- 揭示了一种涉及广泛键网络的激活机制.
- 通过M1745.35形状变化识别了一个含有Piclidenoson N6-iodobenzyl组的神秘口袋.
结论:
- 该研究为A3AR药理学提供了全面的结构和功能见解.
- 这些发现为设计更有选择性的A3AR向疗法奠定了基础.
- 促进对受体激活和连接体相互作用的理解,用于药物发现.
相关概念视频
Adrenergic Receptors: ɑ Subtype
1.8K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.6K
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K


